Your Cart ( 1 Item )
-
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial
January 2018 | Volume 17 | Issue 1 | Original Article | 97 | Copyright © January 2018
Leon H. Kircik MD,a Janet DuBois MD,b Zoe Diana Draelos MD,c Philip Werschler MD FAAD FAACS,d Kimberly Grande MD,e Fran E. Cook-Bolden MD,f Emily Weng ScD MBA,g David R. Berk MD,g and Gurpreet Ahluwalia PhDg
You will have 48 hours to download the full-text PDFPrice
24.95
Total ( 1 Item ) $24.95 CHECKOUT